Adolor Corporation Reports Second Quarter 2008 Financial Results -
Adolor Breaks Support, Hits Monthly Low -
Adolor Corporation (ADLR) Corporate Event Announcement Notice -
Adolor Corp. names Stephen Webster senior vp, CFO; succeeds Hess, who resigned -
Adolor Corporation Names Dr. Guido Magni to the Board of Directors -
Adolor Promotes Dr. Lee Techner to Vice President, Medical Affairs and Medical Director -
Founding Director Robert T. Nelsen to Retire from Adolor Board -
Adolor Advances In Pre-Market On FDA Approval Of Bowel Drug -
Adolor to Host Investor Conference Call to Discuss the FDA Approval of Entereg(R) (alvimopan) -
Adolor, GlaxoSmithKline: FDA OKs Entereg for management of postoperative ileus -
FDA again delays decision on Adolor drug -
Adolor says FDA delays issue of action letter on Entereg -
Adolor Provides Regulatory Update on Entereg(R) (alvimopan) -
Adolor Corporation (ADLR) Corporate Event Announcement Notice -
Adolor Corporation posts figures for first quarter of 2008 -
Adolor Corporation (ADLR) Corporate Event Announcement Notice -